“Biotech Mergers: Evaluating Risk, Reporting, and Integration of Growth Strategies : Gilead’s Acquisition of Immunomedics: Risk and a Growth Strategy ”. The Accounting Educators’ Journal 33 (March 20, 2025). Accessed August 15, 2026. https://www.aejournal.com/ojs/index.php/aej/article/view/1044.